Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmonary disease

Respiratory Research

Volumn 15, Issue 1, 2014, Pages

  Horita, Nobuyuki ^a,b   Miyazawa, Naoki ^b   Morita, Satoshi ^c   Kojima, Ryota ^b   Inoue, Miyo ^b   Ishigatsubo, Yoshiaki ^a   Kaneko, Takeshi ^c  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAISEIKAI YOKOHAMASHI NANBU HOSPITAL   (Japan)

^c YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG FATALITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY (TOPIC); PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX DIFFERENCE; UNITED STATES; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; EVIDENCE BASED MEDICINE; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; AGED; COHORT STUDIES; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MORTALITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84897494972     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-15-37     Document Type: Article

References (21)

1. Williams MH, Seriff NS. Chronic obstructive pulmonary disease:an analysis of clinical, physiologic and roentgenologic features. Am J Med 1963, 35:20-30. 10.1016/0002-9343(63)90160-8, 14046001.
2. Sahn SA. Corticosteroids in chronic bronchitis and pulmonary emphysema. Chest 1978, 73(3):389-396. 10.1378/chest.73.3.389, 344009.
3. Postma DS, Steenhuis EJ, van der Weele LT, Sluiter HJ. Severe chronic airflow obstruction:can corticosteroids slow down progression?. Eur J Respir Dis 1985, 67(1):56-64.
4. Postma DS, Peters I, Steenhuis EJ, Sluiter HJ. Moderately severe chronic airflow obstruction:can corticosteroids slow down obstruction?. Eur Respir J 1988, 1(1):22-26.
5. Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease:a meta-analysis. Ann Intern Med 1991, 114(3):216-223. 10.7326/0003-4819-114-3-216, 1824614.
6. Singh JM, Palda VA, Stanbrook MB, Chapman KR. Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease:a systematic review. Arch Intern Med 2002, 162(22):2527-2536. 10.1001/archinte.162.22.2527, 12456224.
7. Wood-Baker RR, Gibson PG, Hannay M, Walters EH, Walters JA. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005, 1(1):CD001288.
8. Albert RK, Martin TR, Lewis SW. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med 1980, 92(6):753-758. 10.7326/0003-4819-92-6-753, 6770731.
9. Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, Light RW, Anderson P, Morgan NA. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med 1999, 340(25):1941-1947. 10.1056/NEJM199906243402502, 10379017.
10. Quon BS, Gan WQ, Sin DD. Contemporary management of acute exacerbations of COPD:a systematic review and metaanalysis. Chest 2008, 133(3):756-766. 10.1378/chest.07-1207, 18321904.
11. American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995, 152(5 Pt 2):S77-S121. American Thoracic Society.
12. Decramer M, Lacquet LM, Fagard R, Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med 1994, 150(1):11-16. 10.1164/ajrccm.150.1.8025735, 8025735.
13. Walters JA, Walters EH, Wood-Baker R. Oral corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005, 3(3):CD005374.
14. Eliasson O, Hoffman J, Trueb D, Frederick D, McCormick JR. Corticosteroids in COPD:a clinical trial and reassessment of the literature. Chest 1986, 89(4):484-490. 10.1378/chest.89.4.484, 3514164.
15. Renkema TE, Schouten JP, Koeter GH, Postma DS. Effects of long-term treatment with corticosteroids in COPD. Chest 1996, 109(5):1156-1162. 10.1378/chest.109.5.1156, 8625660.
16. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011, Available from:http://www.goldcopdorg/ 2011.
17. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M. UPLIFT study investigators:a 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008, 359(15):1543-1554. 10.1056/NEJMoa0805800, 18836213.
18. The National Emphysema Treatment Trial Research Group Rationale and design of the National Emphysema Treatment Trial (NETT):a prospective randomized trial of lung volume reduction surgery. J Thorac Cardiovasc Surg 1999, 118(3):518-528. The National Emphysema Treatment Trial Research Group.
19. Rosenbaum PR. The central role of the propensity score in observational studies for causal effects. Biometrika 1983, 70(1):41-55.
20. Rice KL, Rubins JB, Lebahn F, Parenti CM, Duane PG, Kuskowski M, Joseph AM, Niewoehner DE. Withdrawal of chronic systemic corticosteroids in patients with COPD:a randomized trial. Am J Respir Crit Care Med 2000, 162(1):174-178. 10.1164/ajrccm.162.1.9909066, 10903238.
21. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids:inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995, 270(5234):286. 10.1126/science.270.5234.286, 7569976.